The qPCR Reagents Market size in Latin America was valued at USD 0.22 billion in 2022 and estimated to be growing at a CAGR of 8.44% to reach USD 0.33 billion by 2027.
QPCR combines PCR amplification and detection into a single step. This eliminates the need to detect products using gel electrophoresis, and more importantly, it enables the method to be used quantitatively. With qPCR fluorescent dyes are used to label the PCR products for thermal cycling.
The procedure is used for forensic, research, and diagnostic purposes and is quickly finding applications in other biological sciences avenues. The term qPCR reagents market defines the market for reagents used in real-time PCR, and common examples include DNA polymerase, dNTP, and Taq Buffer.
The rise of the qPCR Reagents is mainly attributed to the high penetration of the technology among key end-users and the increasing public and private funding to expand the application base of PCR. The ongoing technological advancements and the rise in the geriatric population, and the rising population base for genetic diseases drive the market forwards.
The market is restrained by high costs, technical limitations associated with it, and a lack of skilled personnel.
This research report on the Latin America qPCR reagents market has been segmented and sub-segmented into the following categories:
By Detection Method:
By Packaging Type:
By End User:
Some of the promising companies leading the Latin America qPCR Reagents market are Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., F. Hoffmann-La Roche, Agilent Technologies Inc., Takara Bio, Affymetrix Inc., Promega Corporation, Sigma-Aldrich Corporation, and Quanta Biosciences.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com